Georg Feigl | Clinical Medicine | Research Excellence Award

Published on by Health Scientists

Prof. Dr. Georg Feigl | Clinical Medicine | Research Excellence Award

Institut für Anatomie und klinische Morphologie, Universität Witten | Germany

Prof. Dr. Georg Christoph Feigl is a Germany-based academic researcher at Universität Witten/Herdecke, specializing in clinical anatomy, surgical education, anesthesiology-related anatomy, and cadaver-based medical training. He has authored over 120 peer-reviewed publications, accumulating 2,419 citations with an h-index of 25, reflecting sustained international impact. His research focuses on anatomical optimization for surgical and interventional procedures, including regional anesthesia, orthopedic and thoracic surgery, and advanced cadaveric models (Thiel and Dodge embalming techniques). Prof. Feigl collaborates widely across disciplines, with 300+ co-authors, contributing to translational studies that bridge anatomy, imaging, and clinical practice. His work supports safer surgical techniques, improved medical training, and evidence-based procedural standards, delivering clear societal benefits through enhanced patient safety, education quality, and clinical outcomes.

Citation Metrics (Scopus)

2419
1800
1200
600
0

Citations

2,419

Documents

120

h-index

25

Citations

Documents

h-index

View Scopus Profile
 View ORCID Profile

Featured Publications

Matiyas Mamo Bekele | Clinical Medicine | Research Excellence Award

Published on by Health Scientists

Mr. Matiyas Mamo Bekele | Clinical Medicine | Research Excellence Award

lecturer | University of Gondar | Ethiopia

Matiyas Mamo Bekele is an emerging optometry professional and clinical researcher whose work spans community eye health, refractive error–related quality of life, low-vision challenges, spectacle use, and the broader landscape of preventable visual impairment. As an academic and clinician at the University of Gondar, he integrates teaching, research, and service, contributing to the development of future optometrists, ophthalmic nurses, and ophthalmology residents while also providing comprehensive eye care through both static and outreach platforms. His scholarly work demonstrates a strong orientation toward population-based ophthalmic research, with multiple peer-reviewed publications addressing eye care utilization patterns, spectacle coverage, knowledge and attitudes toward vision correction, and the burden of ocular diseases among diverse communities and at-risk groups, including individuals with diabetes. His collaborative projects with multidisciplinary teams across hospitals, academic institutions, and public health units reflect a commitment to generating evidence that informs national strategies for equitable eye health access. Through his engagement in systematic reviews, clinical investigations, and community-focused studies, he contributes to a growing body of knowledge that supports early detection, appropriate referral pathways, and improved service delivery in low-resource settings. His involvement in national professional bodies and international volunteer organizations further underscores his dedication to strengthening training systems, capacity building, and vision-related advocacy. As a research advisor and mentor, he supports emerging scholars in pursuing impactful inquiry that addresses gaps in vision care and public health. His continuing work advances the understanding of refractive error needs, ocular morbidities, and community-based approaches to blindness prevention, positioned toward improving quality of life and reducing avoidable vision loss across broader populations. He has 10 citations from 13 documents with an h-index of 2.

Profiles: Scopus | ORCID

Featured Publications

1. Hulleck, A. A., Mohan, D. M., Abdallah, N., El Rich, M., & Khalaf, K. (2022). Present and future of gait assessment in clinical practice: Towards the application of novel trends and technologies.

2. Mohan, D. M., Khandoker, A. H., Wasti, S. A., Ismail Alali, S. I. I., & colleagues. (2021). Assessment methods of post-stroke gait: A scoping review of technology-driven approaches to gait characterization and analysis.

3. Jelinek, H. F., Osman, W. M., Khandoker, A. H., Khalaf, K., Lee, S., Almahmeed, W., & colleagues. (2017). Clinical profiles, comorbidities and complications of type 2 diabetes mellitus in patients from United Arab Emirates.

4. Maschirow, L., Khalaf, K., Al-Aubaidy, H. A., & Jelinek, H. F. (2015). Inflammation, coagulation, endothelial dysfunction and oxidative stress in prediabetes—Biomarkers as a possible tool for early disease detection for rural screening.

5. Witzel, I. I., Jelinek, H. F., Khalaf, K., Lee, S., Khandoker, A. H., & Alsafar, H. (2015). Identifying common genetic risk factors of diabetic neuropathies.

Emine Afşin | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Assoc. Prof. Dr. Emine Afşin | Clinical Medicine | Best Researcher Award 

Associate Professor | Bolu Abant Izzet Baysal University | Turkey

Dr. Emine Afşin is a distinguished medical professional and academic whose career reflects a deep commitment to advancing respiratory medicine and public health through clinical excellence, scientific research, and education. As an Associate Professor at Bolu Abant İzzet Baysal University, she has built a robust portfolio of contributions that span clinical practice, scholarly publications, and multidisciplinary collaborations. Her expertise lies in pulmonary diseases, clinical epidemiology, and patient-centered care, with a strong focus on improving diagnostic accuracy and therapeutic outcomes for individuals affected by chronic and infectious respiratory conditions. Dr. Afşin’s research encompasses a wide range of studies addressing disease pathophysiology, healthcare delivery, and preventive interventions, consistently demonstrating her dedication to evidence-based medicine. Her published works in reputable national and international journals have been widely cited, reflecting the impact and relevance of her findings within the global medical community. Through active participation in collaborative research projects, professional societies, and academic conferences, she has fostered strong partnerships that bridge clinical practice and scientific inquiry. Beyond academia, Dr. Afşin is recognized for her role in enhancing healthcare quality, mentoring young physicians, and advocating for equitable access to respiratory health services. Her work continues to contribute meaningfully to both medical science and society, emphasizing innovation, ethics, and human-centered approaches to healthcare advancement. She has 23 citations from 23 documents with an h-index of 2.

Profiles: Google Scholar | Scopus | ORCID
Featured Publications

1. Yılmazer, M., Altındiş, M., Cevrioğlu, S., Fenkci, V., Aktepe, O., & Sırthan, E. (2004). Afyon Bölgesinde yaşayan gebe kadınlarda toksoplazma, sitomegalovirus, rubella, hepatit B, hepatit C seropozitiflik oranları. Afyon Kocatepe Üniversitesi Kocatepe Tıp Dergisi.

2. Oğurlu, M., Sen, S., Polatli, M., Sırthan, E., Gürsoy, F., & Cildağ, O. (2007). The effect of spinal anesthesia on pulmonary function tests in old patients. Tuberkuloz ve Toraks, 55(1), 64–70.

3. Afsin, E., Yaksi, O., Onal, A., & Bacaksiz, E. (2022). Tracheal schwannoma mimicking asthma. International Journal of Neuroscience, 134(5), 436–440. https://doi.org/10.1080/00207454.2021.1999702

4. Afşin, E., & Demirkol, M. E. (2022). Post-COVID pulmonary function test evaluation. Turkish Thoracic Journal, 23(5), 345–350. https://doi.org/10.5152/TurkThoracJ.2022.22023

5.Afşin, E., & Cosgun, Z. (2021). A rare cough complication: Internal oblique muscle hematoma. Radiology Case Reports, 16(5), 1015–1018. https://doi.org/10.1016/j.radcr.2021.01.067

Tana Takacova | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Dr. Tana Takacova | Clinical Medicine | Best Researcher Award

Oncologist | Asklepios Klinik Altona | Germany

Tana Takacova is a physician-scientist specializing in hematology, oncology, and internal medicine with a distinguished academic and clinical trajectory across leading European research and tertiary care institutions. Her expertise spans immuno-oncology, molecular oncology, hematologic malignancies, and translational cancer research, supported by advanced training in oncology from a major German university and extensive postgraduate exposure to molecular biosciences in the United States. She has held clinical roles in prominent university-affiliated hospitals, progressing through multidisciplinary departments including hematology, oncology, palliative medicine, internal medicine, rheumatology, nephrology, gastroenterology, and cardiology, complemented by ongoing training as a prehospital emergency physician. Dr. Takacova has contributed to multiple international research collaborations across Germany, Denmark, Italy, and Slovakia, advancing knowledge in cancer genetics, circulating tumor DNA, oncolytic virus-checkpoint inhibitor synergies, renal cell carcinoma biomarkers, and therapy response prediction. Her peer-reviewed scholarship includes original research articles, systematic reviews, and case-based contributions in oncology and immunology, with additional manuscripts in review and development, reflecting a sustained commitment to evidence-based innovation and emerging therapeutic paradigms in precision oncology. She has presented at international oncology and pharmacology congresses and participates in global research networks and professional societies, reinforcing a truly international academic presence. Her work integrates advanced laboratory skills, clinical trial supervision, systematic review methodology, and bioinformatics-supported analysis, underscoring strong translational orientation. She has been recognized by competitive research fellowships and academic awards and contributes to open-access medical knowledge through educational initiatives such as a freely accessible hematology atlas. Fluent in multiple languages and trained across diverse health systems, she brings a global perspective, resilience in high-pressure environments, and a collaborative approach to clinical care and research leadership, driven by a commitment to advancing cancer diagnostics, therapeutic precision, and equitable patient outcomes worldwide. She has 34 citations from 4 documents with an h-index of 2.

Profile: Scopus

Featured Publications

1. Tana Takacova (2025). Paraneoplastic papillitis as a precursor to colon carcinoma: A case of unexpected vision loss leading to early cancer detection. Oncology Research and Treatment.

Meng Li | Clinical Medicine | Best Medical Scientist Award

Published on by Health Scientists

Mr. Meng Li | Clinical Medicine | Best Medical Scientist Award 

professor | Dandong Central Hospital | China

Dr. Meng Li currently serves as a Teaching Secretary and Professor of General Surgery at China Medical University and is also affiliated with Dandong Central Hospital, the largest Grade-A general hospital in the Liaodong region. She earned her Ph.D. in Oncology from China Medical University, one of the leading medical universities in China. Her primary research focuses on digestive tract tumor surgery, hepatobiliary and pancreatic surgery, gastrointestinal oncology, and the comprehensive treatment of malignant tumors. Over the years, Dr. Li has contributed significantly to the medical research community, publishing seven SCI/Scopus-indexed papers, including works on predictive models for intraabdominal infections after radical gastrectomy, gene signatures in hepatocarcinoma prognosis, and gut microbiota’s role in urological cancers. Her research has accumulated over 47 citations and has advanced understanding in cancer surgery and molecular oncology. In recognition of her outstanding contributions, she received the First Prize of the Liaoning Province Science and Technology Progress Award in 2023. Dr. Li actively participates in collaborative projects, including two National Natural Science Foundation programs, and holds memberships in several professional bodies such as the Chinese Anti-Cancer Association and the Chinese Pancreatic Disease Society. She also serves as an Editorial Board Member of the Cancer Research Journal (CRJ), a guest editor for two scientific journals, and a review editor for others, reflecting her strong commitment to scientific advancement and peer review excellence. Her long-term goal is to deepen molecular insights into cancer and improve clinical outcomes through innovative surgical research. He has 213 citations from 17 documents with an h-index of 7.

Profiles: Scopus | ORCID

Featured Publications

1. Feng, Y., Yang, J., Li, M., Tang, L., Sun, S., & Wang, Y. (2024). A Bayesian network for simultaneous keyframe and landmark detection in ultrasonic cine.

2. Li, Z.-W., Wu, J.-T., Bi, Y., Li, M.-M., Naseem, A., Pan, J., Guan, W., Hao, Z.-C., Kuang, H.-X., & Chen, Q.-S. (2024). A new triterpenoid saponin and a new natural saponin from the roots of Bupleurum scorzonerifolium Willd.

3. Yu, X., Feng, B., Wu, J., & Li, M. (2024). A novel anoikis-related gene signature can predict the prognosis of hepatocarcinoma patients.

4. Yu, X., Tang, W., Bai, C., Li, R., Feng, B., Wu, J., Guo, X., Chen, H., & Li, M. (2024). A predictive model for intraabdominal infection after radical gastrectomy in elderly patients.

5. Li, M., Zhang, X., Chen, K., Miao, Y., Xu, Y., Sun, Y., Jiang, M., Liu, M., Gao, Y., & Xue, X. (2024). Alcohol exposure and disease associations: A Mendelian randomization and meta-analysis on weekly consumption and problematic drinking.

Yang Zhang | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Prof. Dr. Yang Zhang | Clinical Medicine | Best Researcher Award 

Director | Department of Laboratory Medicine Chongqing University | China

Dr. Yang Zhang, Ph.D., currently serves as Director of the Department of Laboratory Medicine at Chongqing University Affiliated Renji Hospital and is an Associate Chief Physician, Postdoctoral Fellow in Clinical Laboratory Diagnostics, and doctoral and master’s supervisor at Chongqing University. She earned her Bachelor of Medicine in Laboratory Medicine (2008), Master of Medicine in Clinical Laboratory Diagnostics (2011), and Ph.D. in Clinical Laboratory Diagnostics (2015) from the Third Military Medical University, complemented by a Ministry of Education-sponsored visiting scholarship at Loma Linda University, USA (2012–2015). Her research centers on precision molecular diagnostics in oncology, with a special focus on POCT rapid diagnostic reagents and spectroscopy-based label-free diagnostic techniques. Dr. Zhang has led multiple high-level research projects, including three funded by the National Natural Science Foundation of China, one by the National Key R&D Program, and numerous provincial and military projects, securing over 6.88 million RMB in funding. She has published more than 40 academic papers as first or corresponding author, with 15 SCI-indexed articles, an H-index of 24, and a single paper cited over 280 times. Her scholarly contributions extend to 12 Chinese invention patents, 1 international PCT patent, and five co-edited scientific monographs, including works on molecular diagnostics and terahertz applications. Dr. Zhang’s achievements have been recognized with numerous honors, such as Chongqing High-Level Young Medical Talent (2022), the “Top Ten Young Scientists in Shapingba District” (2022), First Prize in the Chongqing Association for Science and Technology Innovation (2023), and the National Laboratory Medicine Science and Technology Innovation Award (2021). She also serves as a reviewer for the NSFC and contributes to several national professional committees in laboratory medicine. She has 1044 citations from 43 documents with an h-index of 16.

Profile: Scopus | ORCID 

Publications

1. Zhang, Y. (2020). ENT1 inhibition attenuates apoptosis by activation of cAMP/pCREB/Bcl2 pathway after MCAO in rats. Experimental Neurology, 331, 113362.

2. Zhang, Y. (2020). Identification of immune-related prognostic biomarkers based on the tumor microenvironment in 20 malignant tumor types with poor prognosis. Frontiers in Oncology, 10, 1008.

3. Tian, H., Yuan, C., Liu, Y., Xia, K., Li, M., Xie, F., Chen, Q., Chen, M., Fu, W., & Zhang, Y. (2020, July 28). A sample-to-answer quantification platform for point-of-care testing of circulating microRNAs based on allosteric spherical nanoprobe. Preprint.

4. Zhang, Y. (2020). Evaluation of the reliability of six commercial SERS substrates. Plasmonics, 15(5), 1323–1332.

5. Zhang, Y. (2020). Dataset concerning plasmonic thermal destruction of murine melanoma by gold nanoparticles obtained by green chemistry. Data in Brief, 30, 105370.